Abstract: An antimicrobial toilet includes an inner surface of a toilet bowl which includes a non-doped titanium dioxide coating. The titanium dioxide coating is photocatalytic and antimicrobial in the presence of ultraviolet (UV) light. In the absence of UV light, the inner surface of the toilet bowl is not antimicrobial. The UV light source may be actuated after the waste has exited the toilet bowl. Consequently, the waste may be used in digesters used to produce clean energy or for analysis to assess the user's health status without being exposed to the antimicrobial properties of the titanium dioxide coating. The UV light may then be actuated to disinfect the toilet bowl. The outer shell of the toilet is coated with a doped titanium dioxide. The doped titanium dioxide is photocatalytic and antimicrobial in the presence of visible light. The outer shell is antimicrobial when standard room lights are actuated.

Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition that a user has consumed has decayed in response to storage conditions and time. The taggants may decay in response to environmental conditions which cause different drugs to lose their efficacy. These environmental conditions may include light, temperature, oxidation, moisture, and age. The taggants may be detected in biological samples, including urine and feces. By identifying the taggants, the drug composition and other information relating to the drug may be identified. Additionally, quantification of the different taggants may be used to determine whether the drug in the drug composition has been exposed to environmental conditions which may reduce its efficacy.

Abstract: The drug tracking system may be used to screen a subject's bodily waste and to identify a drug the subject has consumed. The system includes drug tags which include a one or more food dyes, each detectable in a subject's bodily waste using photographic or absorption spectroscopic analysis. The system may further include a database in which is stored the spectral signature of each drug tag and the unique drug associated with each drug tag. A spectral analysis obtained by analyzing a bodily waste sample may be entered into the database. The database may include instructions for comparing the spectral analysis to the spectral signature of each drug tag. The instructions may further report the unique drug associated with a drug tag which has a spectral signature matching the spectral analysis.

Abstract: We disclose a method of tagging a variety of pharmaceutical or nutritional products in which well-studied chemicals may be added to the products in unique ratios. The identities of the chemicals and their relative ratios comprise unique taggants. The taggants may identify which of multiple distinct categories the product falls within. The method includes the step of systematically varying the relative concentrations of the chemicals resulting in multiple ratios of the chemicals. The plurality of ratios of a defined set of chemicals may be collected to form a library of taggants associated with specified items or categories. As the number of chemicals added per product increases, the library supports more categories and the system is less likely to produce a false positive. The method may result in a series of taggants for each item which is single fault tolerant or double fault tolerant.

Abstract: We disclose a tag for tracking and identifying pharmaceutical and nutritional products. The tag includes a paramagnetic microparticle which is connected to at least one unique and detectable chemical. The chemical may be coated on the paramagnetic microparticle or connected through functional groups. The tags may be too large to be taken into the bloodstream and therefore remain in the user's gastrointestinal tract. The tags may be fully or partially isolated from feces for analysis. The tags are attracted to an external electromagnetic force but are not magnetically attracted to each other. Consequently, the tags are safe to ingest. The tags may vary in volume or mass so as to be separable according to mass. The tags may be non-spherical in shape thus increasing the surface area to volume ratio and increasing the amount of chemical which may be attached as a taggant.

Abstract: We disclose an in-toilet urinalysis system which includes a system for collection urine and for analysis of urine components using aptamer technology. Urine collection system may dispense urine into cuvettes, channels, or other containers that include aptamers. The aptamers may detect target molecules in urine. The aptamers may measure urine analytes, detect excreted drugs or drug metabolites, or disease markers. Upon binding to the target molecule, the aptamers may produce a signal which a sensor in the toilet may detect. In some embodiments, the signal may be electrochemical, fluorescent, or colorimetric. The measurements obtained from analysis of the urine may be used to assess a user's health or diagnose disease. In some embodiments, the measurements are stored in a controller which may transmit the measurements to a healthcare provider for assessment.

Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition has decayed in response to environmental conditions and time. The taggants may decay in response to environmental conditions which cause drugs to lose their efficacy. The decay may occur due to improper storage or excursions into certain environmental conditions. These environmental conditions may include light, temperature, moisture, oxidation, and age. By including taggants that have different decay characteristics, the environmental condition that caused the decay may be determined. The amount of time the drug composition was exposed to the environmental condition and the amount of effective drug remaining may also be determined. The disclosed method may reduce the need for a unique assay for each drug to assess decay and determine shelf life. The disclosed method may also be used as a quality control technique for pharmaceutical products.

Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition that a user has consumed has decayed in response to storage conditions and time. The taggants may decay in response to environmental conditions which cause different drugs to lose their efficacy. These environmental conditions may include light, temperature, oxidation, and age. The taggants may be detected in biological samples, including urine and feces. By identifying the taggants, the drug composition and other information relating to the drug may be identified. Additionally, quantification of the different taggants may be used to determine whether the drug in the drug composition has been exposed to environmental conditions which may reduce its efficacy.

Abstract: We disclose a method of tagging nutritional or drug compositions using chemical entities which are known to be safely consumed and which are detectable using known techniques, including near IR spectroscopy. The chemical entities used as tags may be detected in easily obtainable biological samples, including urine and feces. The biological sample may be deposited into a medical toilet which may analyze the biological sample using an analytical device associated with the medical toilet. The tag may be identified and quantified to then identify and quantify the nutritional or drug composition the subject consumed along with the tag. This system may be used to track the source of a food or drug, confirm compliance to a prescribed diet or drug treatment, confirm drug consumption in clinical trials, identify the source of contaminated food, and identify the food substances used to produce food products.

Abstract: We disclose a method of using taggants to assess how and to what extent a drug in a drug composition that a user has consumed has decayed in response to storage conditions and time. The taggants may decay in response to environmental conditions which cause different drugs to lose their efficacy. These environmental conditions may include light, temperature, oxidation, moisture, and age. The taggants may be detected in biological samples, including urine and feces. By identifying the taggants, the drug composition and other information relating to the drug may be identified. Additionally, quantification of the different taggants may be used to determine whether the drug in the drug composition has been exposed to environmental conditions which may reduce its efficacy.

Abstract: The drug tracking system may be used to screen a subject's bodily waste and to identify a drug the subject has consumed. The system includes drug tags which comprise a one or more food dyes, each detectable in a subject's bodily waste using photographic or absorption spectroscopic analysis. The system may further include a database comprising the spectral signature of each drug tag and the unique drug associated with each drug tag. A spectral analysis obtained by analyzing a bodily waste sample may be entered into the database. The database may include instructions for comparing the spectral analysis to the spectral signature of each drug tag. The instructions may further report the unique drug associated with a drug tag which has an spectral signature matching the spectral analysis.

Abstract: We disclose a toilet system which analyzes solid waste to detect tags which were associated with pharmaceutical or nutritional products and excreted in the solid waste of a user. The toilet system may include a receptacle for receiving solid waste, a liquid dispenser for providing a liquid to assist in dispersing the solid waste, a solid waste dispersing system which may mix the solid waste with the liquid thereby homogenizing the solid waste, and an electromagnetic signature detector which may analyze the tags in the solid waste. The electromagnetic signature detector may include a selective binding surface which may bind tags present in the solid waste and which may be connected to a transducer which senses the presence of bound tags.

Abstract: A toilet comprising a rinsing seat, a rimless bowl, and a helical loop trapway is disclosed. An annular cavity for the purpose of storing and dispensing rinse water from the rinsing seat is disclosed. Outlet nozzles arranged about the circumference of the rinsing seat and designed to dispense rinse water at the rimless bowl are disclosed. Rinsing seat supports, hinge assemblies, and seat sensors which offer additional functionality to the rinsing seat are also disclosed. The toilet includes a steep interior surface with a titanium dioxide coating and actuatable ultraviolet light sources. The titanium dioxide has antimicrobial properties in the presence of ultraviolet light to sanitize the toilet. The ultraviolet light source is actuatable to control when the antimicrobial properties of the titanium dioxide coating are activated. The exterior of the toilet is coated with doped titanium dioxide which is antimicrobial in the presence of visible light.

Abstract: We disclose a method of tagging pharmaceutical and nutritional products with nanoparticles which include noble metals. The disclosure describes a plurality of nanoparticles each with either a different size and/or shape. The nanoparticles of different sizes and shapes are distinguishable using spectroscopic techniques because each is associated with different optical properties and have a different spectral signature. The different optical properties are at least due to the unique size or shape of the nanoparticles. Each of the plurality of nanoparticles may be associated with a different characteristic of the tagged pharmaceutical or nutritional product. The method includes mixing the nanoparticles with or adhering the nanoparticles to the tagged pharmaceutical or nutritional product. Two or more of the plurality of nanoparticles may be mixed with or adhered to the tagged pharmaceutical or nutritional product in a ratio and the ratio may be associated with a characteristic of the product.

Abstract: A user-identifying adjustable footstool that is capable of identifying individual users and automatically adjusting based on user-identification. The footstool can save preferences for different users, such as specific heights or angles. These preferences are called when a user is successfully identified by the footstool. The user-identifying adjustable footstool is particularly useful in conjunction with a toilet, to allow users to achieve individualized squatting positions while using traditional western toilets.

Abstract: A toilet comprising a rinsing seat, a rimless bowl, and a helical loop trapway is disclosed. An annular cavity for the purpose of storing and dispensing rinse water from the rinsing seat is disclosed. Outlet nozzles arranged about the circumference of the rinsing seat and designed to dispense rinse water at the rimless bowl are disclosed. Rinsing seat supports, hinge assemblies, and seat sensors which offer additional functionality to the rinsing seat are also disclosed. The toilet includes a steep interior surface with a titanium dioxide coating and actuatable ultraviolet light sources. The titanium dioxide has antimicrobial properties in the presence of ultraviolet light to sanitize the toilet. The ultraviolet light source is actuatable to control when the antimicrobial properties of the titanium dioxide coating are activated. The exterior of the toilet is coated with doped titanium dioxide which is antimicrobial in the presence of visible light.